Research ArticleExperimental Studies
Synergistic and Antagonistic Antiproliferative Effects of Ribociclib (Lee011) and Irinotecan (SN38) on Colorectal Cancer Cells
CHUNG-I HUANG, YI-KAI HUANG, HUI-MING LEE, JIAN-HAN CHEN, YU-CHIEH SU and PAI-MEI LIN
Anticancer Research May 2023, 43 (5) 1933-1941; DOI: https://doi.org/10.21873/anticanres.16353
CHUNG-I HUANG
1Department of Radiation Oncology, E-Da Cancer Hospital, I-Shou University, Kaohsiung, Taiwan, R.O.C.;
YI-KAI HUANG
2Division of General Surgery, E-Da Hospital, I-Shou University, Kaohsiung, Taiwan, R.O.C.;
HUI-MING LEE
3Division of General Surgery, Department of Surgery, E-Da Hospital, I-Shou University, Kaohsiung, Taiwan, R.O.C.;
JIAN-HAN CHEN
3Division of General Surgery, Department of Surgery, E-Da Hospital, I-Shou University, Kaohsiung, Taiwan, R.O.C.;
4Bariatric and Metabolic International Surgery Center, E-Da Hospital, I-Shou University, Kaohsiung, Taiwan, R.O.C.;
5School of Chinese Medicine for Post Baccalaureate, I-Shou University, Kaohsiung, Taiwan, R.O.C.;
YU-CHIEH SU
6Division of Hematology-Oncology, Department of Internal Medicine, E-Da Hospital, I-Shou University, Kaohsiung, Taiwan, R.O.C.;
7Department of Medicine, School of Medicine, I-Shou University, Kaohsiung, Taiwan, R.O.C.;
PAI-MEI LIN
8School of Medicine for International Students and Department of Nursing, School of Medicine, I-Shou University, Kaohsiung, Taiwan, R.O.C.
Log in using your username and password
Purchase access
You may purchase access to this article. This will require you to create an account if you don't already have one.
patientACCESS
patientACCESS - Patients desiring access to articles
In this issue
Synergistic and Antagonistic Antiproliferative Effects of Ribociclib (Lee011) and Irinotecan (SN38) on Colorectal Cancer Cells
CHUNG-I HUANG, YI-KAI HUANG, HUI-MING LEE, JIAN-HAN CHEN, YU-CHIEH SU, PAI-MEI LIN
Anticancer Research May 2023, 43 (5) 1933-1941; DOI: 10.21873/anticanres.16353
Jump to section
Related Articles
- No related articles found.